Search

You searched for "Stone"

1219 results found

Comparison of pathological stage in patients treated with and without neoadjuvant chemotherapy for high-risk UTUC

1 March 2019 | | URO - Urologic Oncology
High-risk upper tract urothelial carcinoma (UTUC) has been associated with poor survival outcomes. The authors evaluated the role of neoadjuvant chemotherapy in high-risk cases prior to radical nephroureterectomy (RNU) in terms of pathological stage of the final surgical specimen. A...

The impact of FGM on the genitourinary system: a 2021 perspective

3 March 2021 | | URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
Awareness of female genital mutilation (FGM) in European countries has increased over recent decades as a result of globalisation and migration of populations. The World Health Organization (WHO) describes FGM as procedures that involve partial or total removal of the...

BAUS 2024 - Welcome from the Honorary Secretary

3 May 2024
Joe Philip. I am thrilled to extend a warm welcome to each and every one of you as we gear up for what promises to be an enriching and enlightening conference experience. On behalf of Mo Belal, the remarkable events...

Urinary incontinence in women – part 1: terminology and diagnosis

1 July 2015 | | URO - Functional / Reconstructive Urology
Introduction Urinary incontinence (UI) is the involuntary and often embarrassing leakage of urine. It is a condition that is both under-reported and under-diagnosed, and when reported it is, unfortunately, often not assessed and managed adequately. Incontinence of urine is encountered...

Feeling like a fraud — imposter syndrome: what it is and what to do about it

17 April 2024 | | URO - Core Urology
Have you ever been plagued by feelings of incompetence despite evidence to the contrary, then this article is for you. Dr Dunay Schmulian provides insight into imposter syndrome and what to do about it. Excerpt 1 Consultant:That was excellent, and...

ICS updates on continence care: making sense of detrusor underactivity and the underactive bladder

1 July 2016 | | URO - Functional / Reconstructive Urology
Countless epidemiological studies have established the frequent occurrence of lower urinary tract symptoms (LUTS) and the significant burden these symptoms incur. For the most part of the past three decades, there has been an overwhelming focus on detrusor overactivity (DO)...

Catheters and incontinence after radical prostatectomy: Preparing (but not scaring) men

1 May 2018 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Urologic Oncology
Every year about 6000 men in the UK undergo radical prostatectomy (RP) for treatment of prostate cancer [1]. Despite surgical advances, RP continues to be associated with significant side-effects including urinary incontinence (UI) [2]. Immediately following removal of the urinary...

Physiotherapy first for pelvic floor dysfunction

1 September 2015 | | URO - Functional / Reconstructive Urology, URO - Urologic Oncology
Physiotherapy should be included in first-line management options for pelvic organ prolapse and urinary incontinence in women [1,2]. Additionally, referral to physiotherapy is widely practised for the management of urinary incontinence in men, faecal incontinence, defecation disorders and various pelvic...

Menopause in Aesthetics 2025

7 February 2025
Menopause in Aesthetics (MiA) returns for its highly anticipated third year! After two groundbreaking events, MiA 2025 promises to push the boundaries of aesthetic medicine and menopause care. This ever-evolving conference and exhibition puts you at the forefront of one...

In conversation with Paula Allchorne

10 March 2022 | URO - Core Urology
We were delighted to catch up with Paula Allchorne, Chair of the European Association of Urology Nurses (EAUN) about her career in urological nursing and her plans for the association. Can you tell us a little bit about what led...

BAUS Annual Meeting 2024

24 June 2024 -26 June 2024
Welcome from the Honorary Secretary I am thrilled to extend a warm welcome to each and every one of you as we gear up for what promises to be an enriching and enlightening conference experience. On behalf of Mo Belal,...

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | URO - Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...